PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway

about

An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

P2860

Q36102008-54039C28-F3F9-4E82-B81D-C48D88C1E5F6

P2860

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway

Item

http://www.wikidata.org/entity/Q36247467

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

PARP Inhibitor PJ34 Suppresses ...... lating BMP-2 Signaling Pathway

@ast

PARP Inhibitor PJ34 Suppresses ...... lating BMP-2 Signaling Pathway

@en

type

Item

label

PARP Inhibitor PJ34 Suppresses ...... lating BMP-2 Signaling Pathway

@ast

PARP Inhibitor PJ34 Suppresses ...... lating BMP-2 Signaling Pathway

@en

prefLabel

PARP Inhibitor PJ34 Suppresses ...... lating BMP-2 Signaling Pathway

@ast

PARP Inhibitor PJ34 Suppresses ...... lating BMP-2 Signaling Pathway

@en

P1476

PARP Inhibitor PJ34 Suppresses ...... lating BMP-2 Signaling Pathway

@en

P2093

Hiroyuki Yamada

http://www.w3.org/2001/XMLSchema#string

Hisako Fujihara

http://www.w3.org/2001/XMLSchema#string

Kazuhito Satomura

http://www.w3.org/2001/XMLSchema#string

Koji Kawaguchi

http://www.w3.org/2001/XMLSchema#string

Mitsuko Masutani

http://www.w3.org/2001/XMLSchema#string

Nanami Yamamoto

http://www.w3.org/2001/XMLSchema#string

Ryoko Nakayama

http://www.w3.org/2001/XMLSchema#string

Yoshiki Hamada

http://www.w3.org/2001/XMLSchema#string

Yuko Fujihara

http://www.w3.org/2001/XMLSchema#string

Yuta Kishi

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-β and BMP signaling in osteoblast differentiation and bone formation

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.

Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours.

Cooperative role of NF-{kappa}B and poly(ADP-ribose) polymerase 1 (PARP-1) in the TNF-induced inhibition of PHEX expression in osteoblasts

Protein malnutrition induces bone marrow mesenchymal stem cells commitment to adipogenic differentiation leading to hematopoietic failure.

The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest.

The telomeric PARP, tankyrases, as targets for cancer therapy

P304

24820-24838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS161024820

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283206275

http://www.w3.org/2001/XMLSchema#string

P698

26492236

http://www.w3.org/2001/XMLSchema#string

P932

4632778

http://www.w3.org/2001/XMLSchema#string

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway

about

P2860

P2860

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932